EtheDent Articles
UK MCA seeks GSL switch for eight drugs
5 July 2001
FDA Panel Backs Fluoride-Based Osteoporosis Drug
27 November 1995
RPSGB CANDIDATES FOR POM-TO-P SWITCHING
2 November 1992
Showing 1-3 of 3 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
